Page 30 - 2021_04-Haematologica-web

I. Henig et al.
graft-versus-host disease (GvHD) with
pooled-donor full ecosystem microbiota bio-
therapeutics. Blood. 2019;134(Suppl_1): 1993. 104.Qi X, Li X, Zhao Y, et al. Treating steroid refractory intestinal acute graft-vs.-host dis- ease with fecal microbiota transplantation:
A pilot study. Front Immunol. 2018;9:2195. 105. van Lier YF, M D, Haverkate NJE, et al. Fecal microbiota transplantation can cure steroid- refractory intestinal graft-versus-host dis- ease. Biol Blood Marrow Transplant
2019;25(3):S241.
106. Bilinski J, Lis K, Tomaszewska A, et al. Fecal
microbiota transplantation as a treatment of severe steroid-resistant acute and chronic graft versus host disease. Spectrum of responses and complications. Blood. 2019;134(Suppl_1):5667.
107.DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-resistant E. coli bacteremia transmit- ted by fecal microbiota transplant. N Engl J Med. 2019;381(21):2043-2050.
108.Modemann F, Ayuk F, Wolschke C, et al. Ruxolitinib plus extracorporeal photo- pheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level. Bone Marrow Transplant. 2020;55(12): 2286-2293.
109. Drexler B, Buser A, Infanti L, Stehle G, Halter J, Holbro A. Extracorporeal photopheresis in graft-versus-host disease. Transfus Med Hemother. 2020;47(3):214-225.
110.Zeiser R, von Bubnoff N, Butler J, et al.
Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382(19):1800-1810.
111. Srinagesh HK, Levine JE, Ferrara JLM. Biomarkers in acute graft-versus-host dis- ease: new insights. Ther Adv Hematol. 2019;10:2040620719891358.
112.Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9(12):1044- 1049.
117.
tion: a randomized clinical trial. JAMA. 2016;315(2):142-149.
Kao D, Roach B, Silva M, et al. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial. JAMA. 2017;318(20):1985-1993.
113.
Davidovics ZH, Michail S, Nicholson MR, et al. Fecal microbiota transplantation for recurrent clostridium difficile infection and other conditions in children: A joint position paper from the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2019;68(1):130-143.
118.Riwes M, Reddy P. Microbial metabolites and graft versus host disease. Am J Transplant. 2018;18(1):23-29.
119.Nguyen CL, Gomes ALC, Peled JU, et al. Antibiotic exposures and dietary intakes are associated with changes in microbiota com- positions in allogeneic hematopoietic stem cell transplant patients. Blood. 2019;134 (Suppl_1):597.
120.Ng SC, Chan FKL, Chan PKS. Screening FMT donors during the COVID-19 pandem- ic: a protocol for stool SARS-CoV-2 viral quantification. Lancet Gastroenterol Hepatol. 2020;5(7):642-643.
121. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to SARS-CoV-2 and COVID-19. Available at https://www.fda.gov/vaccines-blood-bio- logics/safety-availability-biologics/safety- alert-regarding-use-fecal-microbiota-trans- plantation-and-additional-safety-protec- tions. Accessed on July 20, 2020.
122.Nicco C, Paule A, Konturek P, Edeas M. From donor to patient: Collection, prepara- tion and cryopreservation of fecal samples for fecal microbiota transplantation. Diseases. 2020;8(2):9.
114.Cammarota G, Ianiro G, Kelly CR, et al. International consensus conference on stool banking for faecal microbiota transplanta- tion in clinical practice. Gut. 2019;68(12): 2111-2121.
115. Panchal P, Budree S, Scheeler A, et al. Scaling safe access to fecal microbiota transplanta- tion: past, present, and future. Curr Gastroenterol Rep. 2018;20(4):14.
116. Lee CH, Steiner T, Petrof EO, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infec-
946
haematologica | 2021; 106(4)